Unitedhealth Group Inc (UNH)
Health Care · Managed Health Care · US stock · S&P 500 component
$401.43
▼ -5.24 (1.29%)
Fair valueFair
$555 +38.2% to fair value
$277fair band $388–$721$832
Day's range
$395.52 – $412.37
52-week range
$252.96 – $458.79
About Unitedhealth Group Inc
UnitedHealth Group is a health care and insurance company with two main parts. UnitedHealthcare provides health benefit plans to employers, individuals and government programs such as Medicare and Medicaid. Optum offers pharmacy benefit services, care delivery, data analytics and financial services to health systems and payers. The company earns money from premiums paid for insurance coverage and from fees for services, and medical costs strongly influence its profit.
Looking at the top line, revenue was $450.1 billion for the latest twelve months and it grew by 11.4% a year over three years. Operating margin was 4.8%, and return on invested capital is 13%. Its net debt to EBITDA ratio is 1.6 times. Shareholders receive a dividend with a yield of 2.3%. The overall X-Ray Score is 59 out of 100.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
Price chart
52-wk range $252.96 – $458.79Volume 8,106,000Daily, split-adjusted
Vitals
Market cap$363.7B
52-week range$252.96 – $458.79
Volume (last day)8,106,000
P/E (TTM)25.8
EBIT / EV yield5.3%
Free-cash-flow yield6.5%
Dividend yield2.3%
Revenue (TTM)$450.1B
Net income (TTM)$14.1B
Operating margin4.8%
Return on capital12.7%
Debt incl. leases$73.3B
Cash & securities$31.5B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
$555model spread $524 – $594
Fair
+38.2% to fair value
Equal blend of three models: peer multiples, a fundamentals-adjusted multiple (growth, ROIC and margin) and a 10-year DCF scaled to the market's average. Earnings-power value (no growth) is a floor and not part of the blend. Model uncertainty is Medium, so the safety margin is 30%.
Price $401
Undervalued < $388Fair $388 – $721Overvalued > $721
10-year DCF (market-scaled)
$560
Peer multiples
$530
Earnings power floor (not blended)
$343
Fundamentals-adjusted multiple
$574
Growth the price implies
9.8%/yr
A model estimate, not a price target or recommendation. Inputs: risk-free 5.09%, equity risk premium 4.23% (Damodaran). How it works.
What this means
Average business, fairly priced
The price sits inside our fair-value band. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Health Care peers. Open a lens to see the numbers behind it.
Valuation
Strong
76/100
Cheap against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield5.3%
Free-cash-flow yield6.5%
Fair value vs price1.4×
Growth
Fair
52/100
Growing at a typical pace for its sector.
See the numbers →
Revenue growth (3y)11.4%
EPS growth (3y)-14.5%
Growth consistency100%
Profitability
Fair
59/100
Returns on capital are typical for its sector.
See the numbers →
Return on invested capital12.7%
Operating margin4.8%
Gross profitability128.7%
Financial health
Weak
43/100
Balance sheet is more stretched than most peers.
See the numbers →
Piotroski F-Score7 / 9
Net debt / EBITDA1.6×
Interest cover5.6×
Dividends
Fair
64/100
Dividend is typical for its sector.
See the numbers →
Dividend yield2.3%
Dividends vs free cash flow35%
Dividend growth9.7%
Quarterly results: last 6 quarters
+9.8%
Mar '25
+12.9%
Jun '25
+12.2%
Sep '25
+12.3%
Dec '25
+2.0%
Mar '26
+0.4%
Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $112.0B, diluted EPS $6.04.
Compare with peers
ELV Elevance Health, Inc.62 HUM Humana Inc51 CNC Centene Corp46Other Managed Health Care companies by X-Ray Score.
Fundamentals checklist
● 6 Good · ● 4 Average · ● 6 BadCash quality
Earnings backed by cashAverage
Free-cash-flow yieldGood
Risk models
Altman Z''Bad
Piotroski F-ScoreAverage
Growth
EPS growth (3y)Bad
Free-cash-flow growth (3y)Bad
Revenue growth (3y)Good
Growth consistencyGood
Balance sheet
Current ratioBad
Net debt / EBITDAAverage
Interest coverBad
Valuation
Fair value vs priceGood
EBIT / EV yieldGood
Profitability
Return on invested capitalAverage
Operating marginBad
Gross profitabilityGood
Each check is graded against the company's sector, not a fixed number. Checklist score 54/100.
Financials
| FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Revenue | $287.6B | $324.2B | $371.6B | $400.3B | $447.6B |
| Operating income | $24.0B | $28.4B | $32.4B | $32.3B | $19.0B |
| Net income | $17.3B | $20.1B | $22.4B | $14.4B | $12.1B |
| Operating cash flow | $22.3B | $26.2B | $29.1B | $24.2B | $19.7B |
| Operating margin | 8.3% | 8.8% | 8.7% | 8.1% | 4.2% |
| Free cash flow | $19.9B | $23.4B | $25.7B | $20.7B | $16.1B |
| Diluted EPS | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
Fiscal years, from SEC filings.
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
| SMA 10 | 384.1 | Bullish |
| EMA 10 | 387.6 | Bullish |
| SMA 20 | 378.6 | Bullish |
| EMA 20 | 383.6 | Bullish |
| SMA 50 | 386.1 | Bullish |
| EMA 50 | 386.2 | Bullish |
| SMA 100 | 397.7 | Bullish |
| EMA 100 | 383.2 | Bullish |
| SMA 200 | 355.6 | Bullish |
| EMA 200 | 371.5 | Bullish |
Oscillators (daily)
| RSI (14) | 63.28 | Neutral |
| MACD (12, 26) | 2.54 | Bullish |
| Momentum (12) | 9.36 | Bullish |
| Stochastic %K (14) | 75.37 | Neutral |
| Williams %R (14) | -24.63 | Neutral |
| CCI (20) | 227.5 | Bearish |
Pivot points (classic, last session)
S3 377.0 | S2 386.3 | S1 393.8 | Pivot 403.1 | R1 410.7 | R2 420.0 | R3 427.5 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
9.06 USD
Yield on today's price
2.26%
Frequency
Quarterly
Next ex-dividend date
Not announced
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | 2.3200 |
| 15 Jun 2026 | 2.3200 |
| 9 Mar 2026 | 2.2100 |
| 8 Dec 2025 | 2.2100 |
| 15 Sep 2025 | 2.2100 |
| 16 Jun 2025 | 2.2100 |
| 10 Mar 2025 | 2.1000 |
| 9 Dec 2024 | 2.1000 |
| 16 Sep 2024 | 2.1000 |
| 17 Jun 2024 | 2.1000 |
| 8 Mar 2024 | 1.8800 |
| 1 Dec 2023 | 1.8800 |
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
UNH SEC filings
13 Oct 2026
8-KSEC EDGAR
Results of operations
8 Sep 2026
8-KSEC EDGAR
Regulation FD disclosure
10 Aug 2026
10-QSEC EDGAR
Quarterly report
16 Jul 2026
8-KSEC EDGAR
Results of operations
5 Jun 2026
8-KSEC EDGAR
Shareholder vote results
11 May 2026
8-KSEC EDGAR
Regulation FD disclosure
5 May 2026
10-QSEC EDGAR
Quarterly report
21 Apr 2026
DEF 14ASEC EDGAR
Proxy statement
Where the numbers come from
Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.